Trial Profile
Effect of suvorexant in circadian rhythm of blood pressure in hypertensive patients with insomnia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms ESCAPE
- 14 Feb 2019 Status changed from recruiting to discontinued.
- 02 Jul 2015 New trial record